Related Experiment Videos
Extensive bone marrow necrosis associated with antiphospholipid antibodies
The American Journal of Medicine
|June 1, 1995
Summary
Bone marrow necrosis (BMN), a rare condition, was observed in a patient with antiphospholipid syndrome (APS). This case suggests a potential link between APS antibodies and the development of BMN, highlighting a novel association.
Area of Science:
- Hematology
- Immunology
- Pathology
Background:
- Bone marrow necrosis (BMN) is a rare condition characterized by hematopoietic tissue destruction.
- BMN is typically associated with conditions like sickle cell disease, leukemia, neoplasia, and infections, often with hypovolemia or septic shock.
- Disseminated intravascular coagulation (DIC) following irradiation and antineoplastic therapy is also linked to BMN.
Purpose of the Study:
- To report the first recognized case of bone marrow necrosis in a patient with antiphospholipid syndrome (APS).
- To explore the potential role of antiphospholipid antibodies in the pathogenesis of BMN within the context of APS.
Main Methods:
- Morphological definition of bone marrow necrosis.
- Clinical case reporting.
- Review of associated conditions and laboratory findings in antiphospholipid syndrome.
Main Results:
- Bone marrow necrosis was identified in a patient with antiphospholipid syndrome.
- The patient presented with characteristic features of APS, including thrombotic events and thrombocytopenia.
- High titers of antiphospholipid antibodies were noted.
Conclusions:
- This case represents the first documented instance of bone marrow necrosis in antiphospholipid syndrome.
- High titers of antiphospholipid antibodies may be implicated in the pathogenesis of BMN.
- Further research is warranted to elucidate the relationship between APS and BMN.